BioSpace News Archive

Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that Sue Washer, President & Chief Executive Officer, will participate at the OIS Gene Therapy Innovation Showcase, taking place virtually on Thursday, February 18, 2021 from 12:00 PM to 3:00 PM CST.

Anteris Technologies Ltd (ASX:AVR) ( Anteris or the Company ), a structural heart company advancing its novel DurAVR™ valve for aortic repair and replacement, today announced that Wayne Paterson, Chief Executive Officer, will present at the BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Friday, February 19, 2021 at 10:30AM ET.

Quest Diagnostics Incorporated (NYSE: DGX), the world’s leading provider of diagnostic information services, announced that it is scheduled to speak at Citi’s 2021 Healthcare Services, Medtech, Tools, & HCIT Virtual Conference.

Celera Motion, a leader in precision motion component and sub-system solutions and a business unit of Novanta Corporation announces the addition of Capitan Series to their line of premium performance Ingenia servo drives.

Maxwell Biosciences develops antiviral drugs, designed to be Zero-Day Therapeutics, which have been shown in preclinical studies to destroy a broad spectrum of viruses including rapidly evolving Coronavirus strains, announced the appointment of prominent New York University faculty member Kent Kirshenbaum, Ph.D., as the company’s Chief Scientific Officer.

According to a recent analysis conducted by the Harvard Global Health Institute and Brown University School of Public Health for NPR, 4.4 million tests are needed in the U.S. every day to reach a basic level of proactive testing.

Ziopharm Oncology, Inc. (the “Company”) (Nasdaq: ZIOP), today announced the Company will host a conference call and webcast to discuss financial results for the fourth quarter and full year 2020 on Thursday, February 25, 2021 at 4:30pm EDT. The live call can be accessed by dialing 1-877-451-6152 (U.S. and Canada) or 1-201-389-0879 (International). The passcode for the conference call is 13715482. The live webcast may be accessed using the link here

- More than 20 patients have been dosed with CTX001™ across CLIMB-Thal-111 and CLIMB-SCD-121 to date; completion of enrollment in both trials is expected in 2021 - - The first patient treated in the CLIMB-Thal-111 trial completed two years of follow-up and has enrolled in the long-term follow-up trial, CTX001-131 - - Additional data from CTX110™ trial expected to report in 2021, along with top-line data from CTX120™ and CTX130™ -

Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, will present at the BofA Securities Animal Health Virtual Summit on February 25 .

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has granted Priority Review for sotorasib for the treatment of patients with KRAS G12C -mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), followin